OTC:CDSG

Dongsheng Pharmaceutical International Co. Granted Exclusive Sales Rights for Thymosin Alpha 1 Injection

NEW YORK, Jan. 5, 2011 /PRNewswire-Asia/ -- Dongsheng Pharmaceutical International Co., Ltd. (the "Company") (OTC Bulletin Board: DNGH) announced today that it has obtained the exclusive sales rights of Thymosin Alpha 1 Injection in 19 provinces in China from Shanghai Biochemistry Pharmaceutical Co....

2011-01-05 15:40 1398

Dongsheng Pharmaceutical International Co. Acquires Exclusive Intellectual Property, Sales and Manufacturing Rights of Micro-Emulsion Alprostadil Injection

NEW YORK, Nov. 29, 2010 /PRNewswire-Asia/ -- Dongsheng Pharmaceutical International Co., Ltd. (the "Company") (OTC Bulletin Board: DNGH.OB) announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. ("Wan'Te") to acquire the intellectual property, exclusive s...

2010-11-30 14:10 1181

Week's Top Stories